Glenmark Pharmaceuticals recalls 114 batches of Potassium Chloride Extended-Release Capsules due to dissolution failure, posing life-threatening risks.
Glenmark Pharmaceuticals recalls 114 batches of Potassium Chloride Extended-Release Capsules due to dissolution failure, which may cause hyperkalemia and lead to arrhythmias, cardiac arrest, and potentially life-threatening adverse events. The affected products were distributed nationwide and used to treat hypokalemia. No reports of injury related to the recall have been made.
June 25, 2024
3 Articles